Solutions For Challenges Medical Entrepreneurs Face When Creating Biotechnology Startups
dc.contributor | Sessler, Jonathan | |
dc.creator | Xiong, Yuqing | |
dc.date.accessioned | 2019-01-16T16:26:04Z | |
dc.date.available | 2019-01-16T16:26:04Z | |
dc.date.issued | 2017-05 | |
dc.description.abstract | Many obstacles impede the success of biotechnology startups. The Food and Drug Administration's (FDA) clinical trials is one of the primary challenges. The FDA currently imposes rigorous standards before a biotechnology company’s product is approved for dissemination to the public. A result of FDA standards is a costly 7.5-year average product development pipeline that hinders companies, already limited in cash and resources, from quickly generating steady streams of income to sustain their businesses. After a literature review, several important areas of focus were highlighted by individuals who successfully started biotechnology companies or have expertise in the area. They advocated best-practice policies in areas for securing funding, navigating the FDA’s clinical trials, utilizing local resources, and testing products. In addition, a case study was conducted on a Texas-based biotechnology company called Mirna Therapeutics Inc., to highlight some of the best-practices endorsed from literature, as well as to show their limitations. This research could potentially foster a new way of looking at biotechnology startups and provide insightful techniques which entrepreneurs could utilize for their current or future businesses in the field. | en_US |
dc.description.department | Business Administration | en_US |
dc.description.department | Plan II Honors Program | |
dc.identifier | doi:10.15781/T2RN30V0S | |
dc.identifier.uri | http://hdl.handle.net/2152/72421 | |
dc.language.iso | eng | en_US |
dc.relation.ispartof | Plan II Honors Theses - Openly Available | en_US |
dc.rights.restriction | Open | en_US |
dc.subject | Plan II Honors Thesis | |
dc.subject | medical entrepreneur | en_US |
dc.subject | biotechnology startups | en_US |
dc.subject | startup ecosystem and environment | en_US |
dc.subject | best entrepreneurial practices | en_US |
dc.subject | sustainable business models | en_US |
dc.title | Solutions For Challenges Medical Entrepreneurs Face When Creating Biotechnology Startups | en_US |
dc.type | Thesis | en_US |
Access full-text files
Original bundle
1 - 1 of 1
Loading...
- Name:
- xiong_yuqing__Final Complete Thesis.pdf
- Size:
- 391.87 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.66 KB
- Format:
- Item-specific license agreed upon to submission
- Description: